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Background: Serine-arginine-rich (SR)-like proteins regulate the alternative splicing of human genes.
Results: The serine-arginine protein kinase 1 (SRPK1) phosphorylates transformer 2␤1 (Tra2␤1) at numerous sites regulating
RNA binding, splicing of the survival motor neuron 2 gene, and catalytic function of the kinase domain.
Conclusion: The two RS domains interact and regulate Tra2␤1 activity in a phosphorylation-dependent manner.
Significance: SRPK1 is a regulator of Tra2␤1.

The splicing of precursor mRNA transcripts is dependent on
an essential group of splicing factors known as SR3 proteins.
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These factors bind near exon-intron boundaries facilitating the
association of U1 small nuclear ribonucleoprotein and U2AF,
two early components that initiate assembly of the macromolecular spliceosome (1, 2). SR proteins also participate in other
steps along the assembly pathway, including the final step that
generates the active spliceosome (3, 4). SR proteins contain one
or two RNA recognition motifs (RRMs) that bind exonic splicing enhancer (ESEs) sequences near the splice junctions and a
C-terminal Arg-Ser-rich domain (RS domain) that regulates
the former. Although RRMs are compact, folded domains, RS
domains are considered intrinsically disordered (5, 6). The
facilitation of U1 small nuclear ribonucleoprotein and U2AF
attachment to transcripts is dependent on RS domain phosphorylation making SR proteins and their post-translational
modifications necessary for constitutive mRNA splicing (1, 2).
Recent studies suggest that phosphorylation is likely to induce a
conformational change in one SR protein (SRSF1 (SR protein
splicing factor 1 (also known as ASF/SF2)) that exposes its
RRM-promoting interactions with an RRM from the 70K subunit of U1 small nuclear ribonucleoprotein (7). Although this
provides a simple mechanism for exon definition, the link
between splice-site selection and phosphorylation appears to
be much more complex. For example, it has been shown that
varying levels of SR protein phosphorylation correlate strongly
with changes in alternative splicing, a process whereby 5⬘ and 3⬘
splice-site regulation generates multiple mRNA strand isoforms (8 –11). Although alternative splicing is a remarkable
mechanism for proteome diversity and organismal complexity,
little is know about the rules of RS domain phosphorylation and
how graded levels of phosphorylation regulate this process.
Most SR proteins are thought to be poly-phosphorylated
based on numerous Arg-Ser dipeptides within the RS domain
and a strong reactivity with a phosphorylation-sensitive monoclonal antibody, mAb104 (12). Although several protein kinases
phosphorylate SR proteins, two prominent kinase families
serine repeats; RS1, N-terminal RS domain of Tra2␤1; RS2, C-terminal RS
domain of Tra2␤1; SMN, survivor motoneuron gene; SRPK1(6M), SRPK1
with six mutations in docking groove.
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Transformer 2␤1 (Tra2␤1) is a splicing effector protein composed of a core RNA recognition motif flanked by two arginineserine-rich (RS) domains, RS1 and RS2. Although Tra2␤1-dependent splicing is regulated by phosphorylation, very little is
known about how protein kinases phosphorylate these two RS
domains. We now show that the serine-arginine protein
kinase-1 (SRPK1) is a regulator of Tra2␤1 and promotes exon
inclusion in the survival motor neuron gene 2 (SMN2). To
understand how SRPK1 phosphorylates this splicing factor, we
performed mass spectrometric and kinetic experiments. We
found that SRPK1 specifically phosphorylates 21 serines in RS1,
a process facilitated by a docking groove in the kinase domain.
Although SRPK1 readily phosphorylates RS2 in a splice variant
lacking the N-terminal RS domain (Tra2␤3), RS1 blocks phosphorylation of these serines in the full-length Tra2␤1. Thus, RS2
serves two new functions. First, RS2 positively regulates binding
of the central RNA recognition motif to an exonic splicing
enhancer sequence, a phenomenon reversed by SRPK1 phosphorylation on RS1. Second, RS2 enhances ligand exchange in
the SRPK1 active site allowing highly efficient Tra2␤1 phosphorylation. These studies demonstrate that SRPK1 is a regulator of
Tra2␤1 splicing function and that the individual RS domains
engage in considerable cross-talk, assuming novel functions
with regard to RNA binding, splicing, and SRPK1 catalysis.

Phosphorylation of Tra2␤1
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entry of SR proteins, hyper-phosphorylated forms of Tra2␤1
are predominantly localized to the cytoplasm in the brain
rather than the nucleus (30, 31). Furthermore, nuclear import
of Tra2␤1 by TRN-SR1 can occur in a phosphorylation-independent manner (32). Structure-function studies indicate that
the N-terminal RS domain is necessary for Tra2␤1 localization
in nuclear speckles and that phosphorylation promotes cytoplasmic accumulation (31). These findings illustrate that the
cytoplasmic-nuclear distribution of Tra2␤1 is regulated differently than that for most SR proteins. However, despite its functional significance, little is know about the mechanism of
Tra2␤1 phosphorylation. In this study, we show that SRPK1
enhances Tra2␤1-dependent splicing of the SMN2 gene. Based
on mass spectrometric and kinetic methods, we found that
SRPK1 rapidly phosphorylates 21 serines in Tra2␤1 using a
docking groove in the kinase domain. Interestingly, although
SRPK1 can phosphorylate five serines in the C-terminal RS
domain (RS2) in the splice variant lacking RS1 (Tra2␤3), the
presence of RS1 in the full-length form inhibits RS2 phosphorylation suggesting RS domain cross-talk. Nonetheless, RS2 is
not a silent domain. Based on viscosometric and rapid quench
experiments, RS2 coordinately up-regulates phosphorylation
rates in RS1 of Tra2␤1 by increasing the association rate of the
substrate and dissociation rate for ADP in SRPK1. The two RS
domains serve coordinate roles in regulating SRPK1-dependent splicing and RNA binding. Although the unphosphorylated RS2 enhances binding to an ESE, the phosphorylated RS1
blocks this interaction. These studies provide the first detailed
analysis of the phosphorylation of the SR-like protein Tra2␤1.
The results show that the two RS domains in this atypical splicing factor communicate and mutually regulate function.

Experimental Procedures
Materials—ATP, Mops, Tris, MgCl2, NaCl, EDTA, glycerol,
sucrose, acetic acid, Phenix imaging film, BSA, Whatman P81
grade filter paper, and liquid scintillant were obtained from
Fisher. [␥-32P]ATP was obtained from PerkinElmer Life Sciences. RNA (AAGAAC) was purchased from Integrated DNA
Technologies; Hybond ECL nitrocellulose blotting membrane
was purchased from Amersham Biosciences; KinaseMaxTM kit
was purchased form Ambion; and Zip-tip C4 tips were purchased from Millipore. Phos-tag reagent was a generous gift
from Dr. K.-L. Guan, University of California at San Diego.
Protein Expression and Purification—SRPK1, kdSRPK1, and
SRPK1(6M) were expressed from a pET19b vector containing a
His10 tag at the N terminus (33). Tra2␤1, Tra2␤1(⌬RS1), and
Tra2␤1(⌬RS2) were expressed from a pET28a vector containing a C-terminal His6 tag. All mutations were generated using
the QuikChange mutagenesis kit (Stratagene, La Jolla, CA). All
deletion constructs were generated using the Thermo Scientific
Phusion site-directed mutagenesis kit (Integrated DNA Technologies, San Diego). The plasmids for wild-type and mutant
forms of Tra2␤1 and SRPK1 were transformed into the BL21
(DE3) Escherichia coli strain and grown at 37 °C in LB broth
supplemented with 50 g/ml kanamycin and 100 g/ml ampicillin. Protein expression was induced with 1 g/ml isopropyl
1-thio-␤-D-galactopyranoside at room temperature for 4 h for
all Tra2␤1 proteins and with 2.5 g/ml isopropyl 1-thio-␤-DVOLUME 290 • NUMBER 28 • JULY 10, 2015
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(SRPKs and CLKs) have been linked to SR protein-dependent
splicing (8, 9, 13). In recent years, peptide mapping and kinetic
methods have been employed to better define the phosphorylation state and mechanism for SRSF1. The RS domain in this
splicing factor is the smallest within the SR protein family (50
residues) and contains both long and short Arg-Ser dipeptide
repeats that are phosphorylated differentially. SRPK1 (serinearginine protein kinase 1) efficiently targets a long repeat region
in the N-terminal half of the RS domain phosphorylating it in a
strict C- to N-terminal direction (14). This unique mechanism
is semi-processive, and is driven by an electronegative docking
groove in the kinase domain that sequentially feeds dipeptides
into the active site (14 –16). SRPK1 can rapidly phosphorylate
about 9 –12 serines on this Arg-Ser dipeptide stretch, a modification that directs SRSF1 attachment to a specific transportin
(TRN-SR) and subsequent entry into the nucleus (17, 18).
Detailed structure-function studies indicate that SRPK1 mostly
targets longer Arg-Ser repeats in the RS domain of SRSF1 (15).
Although these studies have opened a window into RS domain
phosphorylation, SRSF1 is one of 12 members of the SR protein
family (SRSF1–12) that differ considerably in the position,
number, and length of their Arg-Ser repeat regions (19). How
SRPKs target these diverse RS domains and affect splicing function is still not understood.
Several splicing factors depart from the traditional SR proteins and fall into the category of SR-like proteins. Unlike classic SR proteins, SR-like proteins do not complement SR protein-deficient HeLa cell S100 extracts indicating that they are
not essential for splicing (20). However, they control splice-site
usage and antagonize the actions of traditional SR proteins (21).
One member of the SR-like family is transformer 2 (Tra2), a
protein first identified as a sex-determining factor in Drosophila (22). Although human Tra2 contains an RRM and a C-terminal RS domain, it also contains a long, N-terminal RS
domain distinguishing it from the traditional SR proteins.
One isoform, Tra2␤1 (␤1 isoform of Tra2 protein), has been
shown to regulate gene splicing by binding to precursor mRNA
and working cooperatively with other splicing factors, including SR proteins (23, 24). Tra2␤1 has been implicated in neurodegenerative diseases by controlling specific exon usage in
the tau gene. Several tauopathies, including frontotemporal
dementia and Alzheimer disease correlate with a mis-balance
in the 3R/4R isoforms of the Tau protein (13, 25). The up-regulation of Tra2␤1 may have some therapeutic value in spinal
muscle atrophy which results from a loss of the survival motor
neuron-1 gene (SMN1). Patients have a second copy of the gene
(SMN2) that does not rescue the disease phenotype because
one exon (exon 7) is alternatively spliced producing a truncated,
unstable protein (26). This alternatively spliced form of SMN2
is the result of a single C-to-T change in the ESE of exon 7 (27).
Interestingly, Tra2␤1 expression promotes inclusion of exon 7
resulting in a full-length SMN protein (28).
Although Tra2␤1 is important for splicing, the role of phosphorylation is still not well understood. Prior studies have
shown that Tra2␤1 hyper-phosphorylation, identified by a gel
shift, inhibits RNA binding suggesting a role for kinase-mediated changes in spliceosome assembly and splice-site selection
(29). Although SR protein phosphorylation facilitates nuclear

Phosphorylation of Tra2␤1
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k2 ⫽

kcat/KSR
共kcat/KSR)

(Eq. 3)

where (kcat) and (kcat/KSR) are the slopes of plots of the kinetic
parameter in the absence and presence of viscosogen versus rel
(38). In pre-steady-state kinetic experiments, the reaction
product (P) as a function of time was fit to Equation 4,

关 P兴 ⫽ ␣共1 ⫺ exp共⫺kbt兲兲 ⫹ kLEot

(Eq. 4)

where ␣, kb, kL, and Eo are the amplitude of the “burst” phase,
the rate constant for the burst phase, the rate constant for the
linear phase, and the total enzyme concentration, respectively
(39).

Results
SRPK1 Promotes Tra2␤1-dependent Exon Inclusion in
SMN2—Tra2␤1 has been shown previously to enhance exon 7
inclusion in the SMN2 gene in a concentration-dependent
manner (28). Because SR and SR-like proteins are subject to
phosphorylation-dependent regulation, we wished to determine whether SRPK1 could affect Tra2␤1-dependent splicing.
To accomplish this, we used a minigene in which an alternative
exon is positioned by two constitutive exons in an SMN2
reporter construct (Fig. 1A). We expressed this reporter construct in the absence and presence of enhanced GFP-tagged
Tra2␤1 (EGFP-C2-Tra2␤1) and Myc-tagged SRPK1 (MycSRPK1) vectors in HEK293 cells and monitored changes in
alternative splicing by RT-PCR (30). We found that Tra2␤1
increases exon inclusion in the SMN2 minigene in a concentration-dependent manner (Fig. 1B). This splicing change correlates with increases in Tra2␤1 protein expression based on
Western blotting (Fig. 1D). Importantly, the extent of exon 7
inclusion increases with SRPK1 co-expression (Fig. 1B).
Tra2␤1-induced SMN2 exon inclusion is abolished by expression of an inactive kinase (Myc-kdSRPK1) implying that catalytic activity is required for splicing function (Fig. 1C). These
findings indicate that SRPK1 promotes inclusion of the alternative SMN2 exon 7 most likely by phosphorylating Tra2␤1.
SRPK1 Phosphorylates Numerous Sites in Tra2␤1—To understand how SRPK1 alters SMN2 splicing, we investigated
Tra2␤1 phosphorylation by SRPK1. Tra2␤1 contains two RS
domains with 26 (RS1) and 8 (RS2) Arg-Ser dipeptides that are
potential SRPK1 consensus sites (Fig. 2A). Whether all of these
serines can be modified is not certain. We showed in a previous
study that SRPK1 specifically phosphorylates the last 5 serines
in a splice variant of Tra2␤1 that lacks RS1 (Tra2␤3) suggesting
that the kinase may prefer to target serines in Arg-Ser stretches
rather than isolated dipeptides (34). In this study we will refer to
the splice variant Tra2␤3 as Tra2␤1(⌬RS1). To determine how
many phosphates are added to Tra2␤1, we expressed the fulllength protein in E. coli and analyzed its purity and phosphorylation using a Phos-tag procedure (40). Tra2␤1 phosphorylation by SRPK1 decreases mobility on Phos-tag SDS-PAGE
(⬃160 kDa) compared with Tra2␤1(⌬RS1) (⬃70 kDa) suggesting that more sites are modified in the full-length than the truncated substrate (Fig. 2B). Using MALDI-TOF, a lengthy 2-h
incubation with SRPK1 increased the molecular mass of
JOURNAL OF BIOLOGICAL CHEMISTRY
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galactopyranoside for 12 h for SRPK1 proteins. SRPK1,
SRPK1(6M), and all Tra2␤1 proteins were purified by nickel
resin affinity chromatography using previously published procedures (34).
SMN2 Minigene Splicing Assay—The in vivo splicing of the
SMN2 minigene was carried out using a previously published
procedure (35). Briefly, the SMN2 minigene was transfected
into HEK293 cells with or without Myc-SRPK1 and varying
amounts of EGFP-C2 vector containing the Tra2␤1 cDNAs.
Splice products were analyzed using RT-PCR.
Mass Spectrometry and RNA Binding Experiments—MALDITOF analyses were carried out using a Voyager DE-STR spectrometer. Tra2␤1 constructs (1 M) were incubated with
SRPK1 (200 nM) and 0.3 mM ATP in 25 mM Mops (pH 7.2) and
10 mM free Mg2⫹ for 10 min or 2 h in a total volume of 100 l.
Reaction quenching and desalting were performed according to
a prior method (34). The binding of RNA to the Tra2 proteins
was measured using a nitrocellulose membrane and a Bio-Dot
apparatus (Bio-Rad) according to a previously published protocol (36).
Single-turnover, Manual-mixing Experiments—Tra2 proteins (0.2 M) were incubated with SRPK1 (1 M) and [32P]ATP
(100 M) in a buffer containing 100 mM Mops (pH 7.4), 10 mM
free Mg2⫹, and 5 mg/ml BSA at 23 °C. All reactions were initiated with the addition of enzyme in a total reaction volume of
10 l and quenched with SDS loading buffer. Phosphorylated
protein was cut from an SDS-polyacrylamide gel (12%) and
quantitated on the 32P channel in liquid scintillant using previous methods (34).
Viscosity Experiments—Steady-state phosphorylation was
monitored using a filter-binding assay in 0 –30% sucrose according to previously published procedures (37). The relative
solvent viscosity (rel) of the buffers (100 mM Mops (pH 7.4))
was measured using an Ostwald viscometer and a previously
published protocol (38). rel values of 1.44, 1.83, 2.32, and 3.43
were measured for buffer containing 10, 20, 25, and 30% sucrose
at 23 °C.
Rapid Quench Flow Experiments—Tra2 protein phosphorylation by SRPK1 was monitored using a model RGF-3 quench
flow apparatus (KinTek Corp.). Typical experiments were performed by mixing equal volumes of the SRPK1-Tra2␤1 complex in one reaction loop and [32P]ATP (5000 –15,000 cpm/
pmol) in the second reaction loop in 100 mM Mops (pH 7.4), 10
mM free Mg2⫹, and 5 mg/ml BSA. All enzyme and ligand concentrations are those in the mixing chamber unless otherwise
noted. The reactions were quenched with 30% acetic acid in the
third syringe, and phosphorylated Tra2␤1 was measured using
a filter binding assay (37).
Data Analyses—The rate constants for several steps in the
kinetic mechanism were extracted from viscosity dependences
on the steady-state kinetic parameters according to Equations
1–3,

Phosphorylation of Tra2␤1

Tra2␤1 (35.1 to 37.1 kDa), corresponding to the addition of
about 26 phosphates (Fig. 2C). To determine what subset of
serines is rapidly phosphorylated and likely to be specific sites,
we decreased the incubation time and found that SRPK1 added
21 phosphates in only 10 min (Fig. 2D). These phosphates are
added rapidly with a half-life of ⬃1 min in manual mixing, single-turnover experiments (Fig. 2E). Overall, these findings
show that SRPK1 can rapidly and specifically modify 21 of the
34 potential phosphorylation sites in Tra2␤1.
SRPK1 Uses a “Hit and Run” Strategy for Multisite Tra2␤1
Phosphorylation—The SR protein SRSF1 stays physically associated with SRPK1 during multiple turnover events, whereas
Tra2␤1(⌬RS1) dissociates after each round of phosphorylation
(40, 41). To determine whether the kinase uses a similar mechanism for Tra2␤1, we performed a start-trap experiment in
which kdSRPK1 is added to the reaction to trap any phosphointermediates (42). In this experiment, ATP is added to the
SRPK1-Tra2␤1 complex with and without kdSRPK1 to monitor any changes in the reaction progress curve using the gelbased assay. If Tra2␤1 does not dissociate from SRPK1 during
multisite phosphorylation, kdSRPK1 will not affect the reaction
when added simultaneously with ATP. However, if Tra2␤1 dissociates then kdSRPK1 will trap the intermediates inhibiting
the reaction. We found that the coordinate addition of
kdSRPK1 and ATP to the active enzyme-substrate complex
caused significant reductions in phosphorylation rate compared with the reaction lacking kdSRPK1 (Fig. 3A). In a trapstart control experiment, we pre-equilibrated the SRPK1Tra2␤1 complex with kdSRPK1 before the addition of ATP to
make sure that the trap effectively inhibits the reaction. Preequilibration with kdSRPK1 lowered the initial velocity of the

17272 JOURNAL OF BIOLOGICAL CHEMISTRY

progress curve from 6.5 to 0.3 sites/min (95% inhibition). Overall, we found that the start-trap and trap-start experiments
were very similar suggesting that Tra2␤1 is phosphorylated
using a hit and run strategy where SRPK1 dissociates from the
substrate after each round of catalysis.
Phosphoryl Transfer Step Limits Tra2␤1 Turnover—To determine what limits Tra2␤1 phosphorylation, we initially performed viscosometric experiments and found no changes in
kcat or kcat/KSR up to 30% sucrose, a relative viscosity increase of
over 3-fold (rel ⫽ 3.4) (Fig. 3B). These findings can be understood using the mechanism in Scheme 1, where k2 is the substrate association rate constant; kp is the phosphoryl transfer
rate constant, and k4 is the net product release rate constant
(ADP and phosphoprotein). We showed previously that these
rate constants can be measured from the relative changes in
kinetic parameters versus relative viscosity (rel) using Equations 1–3. Thus, in the absence of a viscosity effect on kcat (i.e.
⫺(kcat) ⬃0), kp limits maximum turnover (0.36 s⫺1), and k4 is
fast (⬎4 s⫺1) (Table 2). The absence of a viscosity effect on
kcat/KSR implies that the association rate constant for the protein is much larger than kcat/KSR and k2 ⬎40 M⫺1 s⫺1 (Table
2). To confirm these results, we showed that the production of
phospho-Tra2␤1 is linear in rapid quench flow experiments
and shows no signs of a burst phase (Fig. 3C). Enzyme-normalized slopes close to kcat (0.3 s⫺1) were obtained, implying that
the phosphoryl transfer step fully limits kcat. Finally, to better
define multisite phosphorylation, we performed a single turnover experiment in the rapid quench flow machine and showed
that the first five phosphates are added in a time frame consistent with the steady-state and pre-steady state kinetic data (Fig.
3D). Interestingly, the phosphorylation rate per site declines
VOLUME 290 • NUMBER 28 • JULY 10, 2015
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FIGURE 1. SRPK1 induces Tra2␤1-dependent splicing of SMN2. A, SMN2 minigene. B and C, SMN2 minigene splicing as a function of Tra2␤1 and SRPK1 (B)
or kdSRPK1 (C) in HEK293 cells. D, Western blot (WB) detection of Tra2␤1 in HEK293 cells.

Phosphorylation of Tra2␤1

from 0.38 s⫺1 in the first five additions to 0.11 s⫺1 in the
remaining additions suggesting that later phosphorylation
events become slightly more difficult (Fig. 3D). Overall, the
combined viscosometric and pre-steady-state kinetic data confirm that the phosphoryl transfer step limits Tra2␤1 turnover.
RS1 Down-regulates RS2 Phosphorylation—Although we
showed previously that SRPK1 modifies 5 serines in the splice
variant Tra2␤1(⌬RS1) (40), it is unclear whether these sites or
any others in RS2 are also phosphorylated in the full-length
Tra2␤1. To address this, we initially removed a cluster of four
possible phosphorylation sites in RS2 in Tra2␤1(QM) (Fig. 4A).
Based on Phos-tag SDS-PAGE, Tra2␤1(QM) migrates similarly
as Tra2␤1 with and without SRPK1 treatment (Fig. 4B), suggesting that SRPK1 may phosphorylate the mutant substrate as
well as Tra2␤1. In MALDI-TOF experiments, Tra2␤1(QM)
and Tra2␤1 were equally phosphorylated after a 10-min incubation with SRPK1 suggesting that RS2 is unlikely to be phosphorylated (Fig. 4C). To support this, we expressed a form of
Tra2␤1 lacking RS2 and all eight serines, Tra2␤1(⌬RS2) (Fig.
4A), and we found that SRPK1 induced a large mobility shift
JULY 10, 2015 • VOLUME 290 • NUMBER 28

(⬃120 kDa; Fig. 4D). The magnitude of this shift is lower than
that for Tra2␤1, which could be the result of either a change in
protein size and gel shift or a true decrease in overall phosphorylation. To address this, we measured the phosphoryl content
of Tra2␤1(⌬RS2) using MALDI-TOF and showed that after a
10-min or 2-h incubation with SRPK1, the molecular mass
increased to a level consistent with about 21 or 27 phosphates
(Fig. 4, E and F). These results are similar to those for the fulllength substrate (Fig. 1) suggesting that SRPK1 phosphorylates
RS1 rather than RS2 in Tra2␤1. In summary, we conclude that
RS1 not only is the major site for SRPK1 phosphorylation in
Tra2␤1 but also down-regulates phosphorylation in RS2.
RS2 Enhances ADP Release and Substrate Association Rates
in SRPK1—Although RS2 plays no role in controlling the
Tra2␤1 phosphoryl content, we wished to determine whether it
could affect the phosphorylation mechanism. In steady-state
kinetic assays, we found that kcat and kcat/KSR values for
Tra2␤1(⌬RS2) are about 3- and 9-fold lower than that for
Tra2␤1 (Table 1). To determine the cause of these decreases,
we performed viscosity experiments. Whereas sucrose had
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 2. Tra2␤1 phosphorylation by SRPK1. A, RS domains (RS1 and RS2) in Tra2␤1 and Tra2␤1(⌬RS1). B, Phostag SDS-PAGE of Tra2␤1 and Tra2␤1(⌬RS1)
with and without SRPK1 phosphorylation. C and D, MALDI-TOF of Tra2␤1 with SRPK1 after 10 min (C) and 2 h (D) of incubation with ATP. The molecular mass
of Tra2␤1 increases by 1.64 and 2.05 kDa after 10-min and 2-h incubations. E, SRPK1 phosphorylation of Tra2␤1 by autoradiography. Data were fit to a rate
constant of 0.6 min⫺1 and 21 total sites.

Phosphorylation of Tra2␤1

SCHEME 1

no effect on Tra2␤1, both kcat and kcat/KSR values for
Tra2␤1(⌬RS2) were significantly reduced (Fig. 5A). Ratio plots
of kcat and kcat/KSR in the absence and presence of sucrose (relative parameter) versus relative viscosity (rel) are linear with
slopes close to the theoretical upper limit of 1 (Fig. 5B). This
suggests that, unlike the full-length substrate, Tra2␤1(⌬RS2)
phosphorylation is limited by net product release (k4) (Table 2).
Using Equation 3 and the viscosity effects on kcat/KSR, we
show that this parameter directly measures the substrate
association rate constant (k2) (Table 2). These findings indicate that RS2 increases the substrate association rate to SRPK1
by about 2 orders of magnitude (Table 2). To confirm that the
phosphoryl transfer step is not rate-limiting for kcat, we performed pre-steady-state kinetic experiments. We found that
Tra2␤1(⌬RS2), unlike the full-length substrate, is phosphorylated in a biphasic manner with an initial burst phase (kb ⫽ 1
s⫺1) followed by a linear steady-state phase (kL ⫽ 0.11 s⫺1) (Fig.
5C). The presence of a burst indicates that the phosphoryl
transfer step for Tra2␤1(⌬RS2) is fast and does not limit kcat.
Overall, these data show that the addition of RS2 increases substrate association and net product release rates.
To isolate the rate-limiting step for Tra2␤1(⌬RS2) phosphorylation, we performed a catalytic trapping experiment in which
the SRPK1-Tra2␤1(⌬RS2) complex is pre-equilibrated with
ADP before mixing with excess [32P]ATP in the rapid quench
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flow machine (43). Without ADP pre-equilibration, we observed burst kinetics that were simulated using the mechanism
in Scheme 2 and the program DynaFit (Fig. 5D) (44). Using a
fixed value for the ATP kon (0.013 M⫺1 s⫺1) based on kcat/
KATP, we obtained values of 0.45 and 0.11 s⫺1 for kp and k4
(Table 2). The latter reflects the net rate constant for product
release, and its value is consistent with kcat (Table 1). Pre-equilibration of the complex with ADP leads to a loss of the burst
phase and the generation of a small lag prior to resumption of
steady-state turnover (Fig. 5D). The linear phases with and
without ADP are similar indicating that sufficient ATP traps
any free complex. The data in the presence of ADP were simulated using the mechanism in Scheme 2. By fixing kon, kp, and k4,
we obtained a value of 0.16 s⫺1 for the ADP koff (kADP). These
findings indicate that maximum turnover of Tra2␤1(⌬RS2) is
mostly limited by ADP release. By considering the simulated
values of kp (0.45 s⫺1) and kADP (0.16 s⫺1), we can calculate a
lower limit for the release rate of phospho-product (kpSR) of 2
s⫺1 (Table 2). By comparing Tra2␤1 and Tra2␤1(⌬RS2), we
conclude that RS2 enhances overall RS domain phosphorylation by increasing kADP from 0.16 to ⬎4 s⫺1 and by increasing k2
from 0.41 to ⬎40 M⫺1 s⫺1 (Table 2). Despite these changes,
RS2 has no detectable effect on the phosphoryl transfer rate.
Efficient RS1 Phosphorylation Requires the Docking Groove—
In previous studies we showed that although efficient phosphorylation of SRSF1 requires the docking groove in SRPK1, the
shorter repeat in Tra2␤1(⌬RS1) does not (40). We wished to
learn whether RS1 phosphorylation in the full-length Tra2␤1
also requires this docking groove. We initially confirmed that
VOLUME 290 • NUMBER 28 • JULY 10, 2015
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FIGURE 3. Kinetic analysis of Tra2␤1. A, start-trap experiment. SRPK1 (1 M) and Tra2␤1 (0.2 M) are pre-equilibrated before addition of ATP (50 M) in the
absence (F) and presence (Œ) of kdSRPK1 (60 M). The data in the absence of kdSRPK1 are fit to a rate constant of 0.31 min⫺1 and an end point of 21 sites. A
control reaction is run by pre-equilibrating SRPK1, kdSRPK1, and Tra2␤1 prior to ATP addition (f) and fit to a slope of 0.29 sites/min. B, viscosity experiments.
Initial velocity of SRPK1 is measured as a function of Tra2␤1 at varying amounts of sucrose. The data at 0% sucrose are displayed in Table 1. C, rapid quench flow
experiments. Tra2␤1 (3 M) is pre-equilibrated with 0.2 (Œ) and 0.5 M (F) SRPK1 and then reacted with 50 M ATP. The data are fit to slopes of 0.06 and 0.14
M/s at 0.2 and 0.5 M SRPK1. D, single turnover experiment. SRPK1 (2 M), Tra2␤1 (0.4 M), and ATP (100 M) are reacted in the rapid quench flow instrument,
and the number of sites are plotted with time (0.1–240 s). The data are fit to a double exponential with amplitudes and rate constants of 5.0 and 16 sites and
0.075 and 0.0065 s⫺1.
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FIGURE 4. Mutation of phosphorylation sites in RS2. A, Ser-to-Ala mutations and deletion constructs of RS2. B, Phos-tag SDS-PAGE analysis of Tra2␤1(QM)
and Tra2␤1 with and without SRPK1 phosphorylation. C, MALDI-TOF of Tra2␤1(QM) after a 10-min incubation with SRPK1 and ATP. The molecular mass of
Tra2␤1(QM) increases by 1.65 kDa (21 phosphates). D, Phos-tag SDS-PAGE analysis of Tra2␤1(⌬RS2) with and without SRPK1 phosphorylation. E and F,
MALDI-TOF of Tra2␤1(⌬RS2) after 10-min (E) and 2-h (F) incubation with SRPK1 and ATP. The molecular mass of Tra2␤1(⌬RS2) increases by 1.64 and 2.11 kDa
after 10-min and 2-h incubations.

TABLE 1
Steady-state kinetic parameters for the phosphorylation of wild type and mutant Tra2␤1 proteins
Substrate
Tra2␤1
Tra2␤1(⌬RS2)
Tra2␤1(⌬RS1)
a

kcat

KSR

kcat/KSR

KATP

kcat/KATP

s⫺1

nM

M⫺1 s⫺1

M

M⫺1 s⫺1

0.36 ⫾ 0.02
0.11 ⫾ 0.01
0.032a

110 ⫾ 16
270 ⫾ 60
35a

3.6 ⫾ 0.53
0.41 ⫾ .10
0.91a

10 ⫾ 2
9⫾4
11a

40 ⫾ 8.1
12 ⫾ 5.4
2.9a

Data were reported previously (34).

Tra2␤1(⌬RS1) does not require this groove, as reported previously (40), by showing that phosphorylation is not diminished
by a mutant SRPK1, SRPK1(6M), that lacks a functioning dockJULY 10, 2015 • VOLUME 290 • NUMBER 28

ing groove (Fig. 6A). SRPK1(6M) contains alanine mutations in
six electronegative residues in the docking groove of the kinase
domain (33). In contrast to Tra2␤1(⌬RS1), we found that the
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TABLE 2
Individual rate constants associated with the phosphorylation of wild
type and mutant Tra2␤1 proteins
Rate constant
⫺1 ⫺1

k2 (M s )
kp (s⫺1)
k4 (s⫺1)
kADP (s⫺1)
kp, SR (s⫺1)
a
b
c

Tra2␤1

Tra2␤1(⌬RS2)

ⱖ40
0.30c (0.36a)
ⱖ4a
⬎4a
⬎4a
a

a

0.41
0.45c
0.11a,c
0.16c
⬎2a

Tra2␤1(⌬RS1)
1.1b
0.23b
0.028b
0.34b
0.030b

Data were determined using viscosometric experiments and Equations 1–3.
Data were previously reported (34).
Data were determined using rapid quench flow experiments.

SCHEME 2

rate for Tra2␤1 was much lower for SRPK1(6M) compared with
the wild-type kinase over the assay time course suggesting that
the lengthy repeats in RS1 require the docking groove (Fig.
6B). Tra2␤1(⌬RS2) also requires the docking groove for rapid
multisite phosphorylation (Fig. 6C). Overall, these findings suggest that the docking groove plays an important role in regulating the efficiency of RS1 phosphorylation and that RS2,
although not phosphorylated, likely plays a role in positioning
RS1 in this groove.
RS2 Enhances RNA Binding to Tra2␤1—Having shown that
RS2 augments the rate of Tra2␤1 phosphorylation by SRPK1,
we next wondered whether this C-terminal RS domain could

17276 JOURNAL OF BIOLOGICAL CHEMISTRY

also impact RRM function. To accomplish this, we monitored
the interaction of Tra2␤1 and the two RS domain deletion constructs with an RNA sequence based on the consensus ESE for
Tra2␤1 (AAGAAC) using a filter binding assay (22). We found
that Tra2␤1 along with Tra2␤1(⌬RS1) and Tra2␤1(⌬RS2) bind
cooperatively to the ESE (Fig. 7A and Table 3). Because of the
small length of the RNA strand, the observed cooperativity is
likely the result of protein-protein interactions that enhance
RNA association with the RRM. Although the three proteins
showed similar Hill coefficients, they displayed differences in
overall binding affinities (K0.5). Whereas Tra2␤1(⌬RS1) binds
with similar affinity as the full-length protein, Tra2␤1(⌬RS2)
displayed reduced binding affinity (Fig. 7A and Table 3).
Because of the high level of cooperativity, this 2-fold change in
binding has significant impact on the bound states. For example, at concentrations near K0.5 (8 M), 10 times more Tra2␤1 is
bound to RNA compared with Tra2␤1(⌬RS2) (Fig. 7A). These
findings suggest that the ability of the RRM to associate with
RNA is enhanced by the presence of RS2. To determine
whether the RS domain could bind in the absence of the RRM,
we expressed and purified a His-tagged form of RS2. We found
essentially no binding up to 14 M RS2, the highest concentration achievable for this construct, whereas 90% of the RNA is
bound at a similar concentration of Tra2␤1(⌬RS1) or Tra2␤1
(Fig. 7A). These results indicate that RS2 does not interact
directly with RNA but instead induces a higher affinity form of
the RRM.
Phosphorylation Dissociates the Tra2␤1-RNA Complex—To
ascertain whether phosphorylation alters RNA binding, we
pre-formed RNA-protein complexes and asked whether
VOLUME 290 • NUMBER 28 • JULY 10, 2015
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FIGURE 5. Kinetic analysis of Tra2␤1(⌬RS2). A, viscosity experiments. Initial velocity of SRPK1 is measured as a function of Tra2␤1(⌬RS2) at varying sucrose
amounts. The data fits at 0% sucrose are displayed in Table 1. B, viscosity plot. The relative parameters for kcat (F) and kcat/KSR (E) in the absence and presence
of viscosogen are plotted as a function of relative viscosity (rel). Theoretical slope values of 0 and 1 are shown as dashed lines. C, rapid quench flow experiments.
Tra2␤1(⌬RS2) (1 M) is pre-equilibrated with 0.2 M SRPK1 before 50 M ATP addition. The data are fit to Equation 4 to obtain values of 0.12 ⫾ 0.01 M, 1.0 ⫾
0.2 s⫺1, and 0.11 ⫾ 0.04 s⫺1 for ␣, kb, and kL, respectively. D, catalytic trapping (CATTRAP) experiments. SRPK1 (0.4 M) and Tra2␤1(⌬RS2) (1 M) are preequilibrated with (Œ) and without (F) ADP (60 M) before ATP addition (600 M). The data are simulated using the mechanism in Scheme 2 to obtain values of
0.45, 0.11, and 0.16 s⫺1 for kp, k4, and kADP, respectively (Table 2).
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FIGURE 6. Role of docking groove for substrate phosphorylation. ATP (100
M) and 1 M SRPK1 (F) or SRPK1(6M) (Œ) are reacted with 0.2 M
Tra2␤1(⌬RS2) (A), Tra2␤1 (B), or Tra2␤1(⌬RS2) (C).

TABLE 3
Binding of RNA to mutant and wild type Tra2␤1 proteins
Protein

K0.5

N

M

SRPK1 phosphorylation affects their bound states. For these
experiments, we fixed the total protein concentrations near
K0.5 so that we could sensitively measure small increases/
decreases in phosphorylation-dependent RNA binding. We
found that SRPK1 phosphorylation of all three proteins
significantly reduced RNA binding (Fig. 7B). To ensure that
this reduction is not due to a secondary binding event, we
showed that the addition of SRPK1 or ATP to the proteinRNA complex did not induce dissociation (Fig. 7B). Assuming similar levels of binding cooperativity, these findings
suggest that SRPK1 phosphorylation reduces RNA affinity
by ⬃2-fold to Tra2␤1(⌬RS1) and Tra2␤1(⌬RS2) and 4-fold
to Tra2␤1. These results demonstrate that the two RS domains serve opposing, phosphorylation-dependent roles
with regard to RNA binding. Whereas RS2 supports RNA
binding in unphosphorylated Tra2␤1, RS1 inhibits binding
in phosphorylated Tra2␤1.
JULY 10, 2015 • VOLUME 290 • NUMBER 28

Tra2␤1
Tra2␤1(⌬RS1)
Tra2␤1(⌬RS2)

7.7 ⫾ 0.32
8.0 ⫾ 0.16
18 ⫾ 0.35

3.3 ⫾ 0.44
3.1 ⫾ 0.20
3.7 ⫾ 0.20

SRPK1 Activation of Tra2␤1-dependent SMN2 Splicing
Requires RS1 and RS2—Previous studies demonstrated that
removal of either RS1 or RS2 reduces exon 7 inclusion in the
SMN2 minigene by about 30% suggesting that both RS
domains are required for efficient Tra2␤1-dependent splicing (45). We wished to address whether both RS domains are
required for SRPK1-dependent splicing activation. We found
that SRPK1 expression did not increase exon 7 inclusion in the
SMN2 minigene when co-expressed with either Tra2␤1(⌬RS1)
or Tra2␤1(⌬RS2) (Fig. 8). Deletion of either RS1 or RS2 lowered
exon 7 inclusion by 20 – 40% indicating that SRPK1 does not
rescue this phenotype. These findings suggest that both RS
domains are required for SRPK1-dependent activation of
Tra2␤1-induced splicing.
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 7. Interactions of SMN ESE with wild-type and mutant forms of
Tra2␤1. A, binding profile. ESE from SMN is equilibrated with Tra2␤1,
Tra2␤1(⌬RS1), and Tra2␤1(⌬RS2) and the fraction bound is plotted against
varying protein concentrations. Parameter fits for the data are displayed in
Table 3. B, change in fractional bound RNA as a function of phosphorylation.
ESE from SMN is equilibrated with fixed amounts of Tra2␤1 proteins at their
K0.5 values (Table 3) and then treated with SRPK1, ATP, or SRPK/ATP. The
change in fractional bound RNA is displayed relative to the ESE-protein complex in the absence of any additional agents.

Phosphorylation of Tra2␤1

FIGURE 8. Role of RS1 and RS2 for SRPK1-dependent splicing of SMN2. SMN2 splicing is monitored in the presence of Tra2␤1(⌬RS1) or Tra2␤1(⌬RS2) and
SRPK1 expression in HEK293 cells.

Discussion
Detailed studies of the prototype SR protein SRSF1 suggest
that SRPKs target lengthy Arg-Ser repeats phosphorylating
them in a C-to-N directional manner (15). The efficiency of this
process is guided by a docking groove in the kinase domain of
SRPK1 that feeds Arg-Ser dipeptides to the active site. In this
work we address how SRPK1 phosphorylates Tra2␤1, an SRlike protein that contains two RS domains and controls gene
splicing in a phosphorylation-dependent manner (10, 46).
Interestingly, although most SR proteins gain entry into the
nucleus through a phosphorylation-dependent process, hyperphosphorylation drives Tra2␤1 into the cytoplasm (30, 31),
similar to that for the splicing regulator hnRNP1 (47). We show
for the first time that SRPK1 directly phosphorylates Tra2␤1, a
modification that regulates the alternative splicing of the SMN2
gene. Because of the role of this gene in spinal muscle atrophy,
SRPK1 expression and its Tra2␤1-dependent phosphorylation
activity could serve a positive role in tipping the balance from
truncated to full-length SMN proteins, leading to possible therapeutic avenues for treating this disease. We show that the two
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RS domains in Tra2␤1 engage in extensive cross-talk that regulates not only protein phosphorylation of the domains but also
RNA binding and ligand exchange events in SRPK1.
Eliminating the Competition by Changing Strategies—Although we showed in a previous study that RS2 in the splice
variant Tra2␤1(⌬RS1) is a good substrate for SRPK1 (34), the
introduction of RS1 in the full-length splicing factor profoundly affects access to RS2. The switch from RS2 to RS1
phosphorylation in Tra2␤1 is surprising for two reasons. First,
Tra2␤1(⌬RS1) binds with 4-fold higher affinity than the fulllength Tra2␤1 to SRPK1 (Table 1) suggesting the formation of a
highly productive enzyme-RS2 complex. Second, the phosphoryl transfer rate in the active site of SRPK1 (kp) is the same for
Tra2␤1 and Tra2␤1(⌬RS1) (Table 1), an observation suggesting
that RS2 is well aligned for efficient in-line transfer. If we compare the catalytic efficiencies of SRPK1 for Tra2␤1(⌬RS1) and
Tra2␤1(⌬RS2) using kcat/KSR as a metric (Table 1), we would
anticipate that RS2 is more likely to be phosphorylated than
RS1, the opposite of our findings. To explain this paradox,
we propose that the two RS domains interact differentially
VOLUME 290 • NUMBER 28 • JULY 10, 2015
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FIGURE 9. Effects of RS domain on Tra2␤1 and SRPK1 function. A, RS2 disengages from the RRM in Tra2␤1(⌬RS1). B, coordinate roles of RS1 and RS2 on
phosphorylation and RNA binding in Tra2␤1. C, RS2 accelerates Tra2␤1 phosphorylation by enhancing protein substrate association and product release rates.
Free energy profile compares relative changes for Tra2␤1 (black) and Tra2␤1(⌬RS2) (red).
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and kcat/KSR implies that the C-terminal RS domain is a positive
regulator of SRPK1 irrespective of any changes in the cellular
levels of Tra2␤1. The underlying causes of this concentrationindependent enhancement are best described in a reaction-free
energy profile (Fig. 9C). Although RS2 has no effect on the
phosphoryl transfer rate, it greatly increases the rates of two
ligand exchange events, substrate binding and product release.
We showed that RS2 amplifies the association rate constant for
Tra2␤1 by at least 100-fold and increases ADP release by about
20-fold (Table 2). The former result could be due to an inductive effect across the substrate that helps align RS1 for productive encounters with SRPK1. Also, it is possible that the RRMRS2 pair makes direct contacts with SRPK1 assisting RS1 into
the active site. The latter mechanism may also provide a means
for assisting ADP release. In previous studies we showed that
the N-terminal extension and a helix in an insert domain in
SRPK1 constitute a nucleotide release factor that accelerates
ADP dissociation through interactions with a portion of the RS
domain in SRSF1 (51, 52). Using this precedent, it is possible
that the RRM-RS2 pair in Tra2␤1 interacts with this factor
accelerating ADP release from SRPK1. Our studies on the atypical splicing factor Tra2␤1 now show that phosphorylation can
also be accelerated by secondary RS domains distal from the
primary RS domain target.
Conclusions—In this study we demonstrate for the first time
that SRPK1 can phosphorylate Tra2␤1 and induce exon inclusion in the SMN2 gene. The phosphorylation mechanism for
Tra2␤1 departs from the classic paradigm established for the
prototype SR protein SRSF1. The two RS domains (RS1 and
RS2) act in a synergistic manner not only to regulate the availability of serines for phosphorylation but also to manipulate the
kinetic mechanism of SRPK1 (Fig. 9). Although both RS domains contain consensus serines for SRPK1, RS1 down-regulates phosphorylation of the RS2 serines. Both domains play
phosphorylation-dependent and -independent functions in
RNA binding. The unphosphorylatable RS2 domain enhances
RNA binding to RRM, whereas the phosphorylated RS1 domain
diminishes this activity. The phosphorylation-dependent release of RNA could then facilitate transport of Tra2␤1 to the
cytoplasm. Although not a target for SRPK1, RS2 can enhance
the interactions of RS1 with the active site of SRPK1 and promote efficient substrate turnover by increasing product dissociation. The cooperativity between RS1 and RS2 is essential for
the SRPK1-dependent effects on SMN2 splicing. These findings
significantly broaden our understanding of how RS domains in this
splicing factor are phosphorylated and how Arg-Ser repeats widely
separated in sequence can cross-regulate function.
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RS Domain Regulates Ligand Exchange in SRPK1—In addition to important internal contacts within Tra2␤1, we found
that the RS domains can also regulate the catalytic efficiency of
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